FY2022 · Annual report
Form 10-K · March 2, 2023 · 264 pages
Read Xilio Therapeutics, Inc.'s results firsthand
Preview the first 2 pages of this annual report
Create a free account to start reading
Full documents are included with Professional
Xilio Therapeutics, Inc.
NNASDAQ:XLO8.71
USD
+0.03
(+0.35%)
